IFN-γ: Signaling Pathway Decoding and Research Approaches

Interferon-gamma (IFN-γ), also known as type II interferon, is a pleiotropic cytokine crucial in cellular immune responses. Unlike type I interferons, IFN-γ is primarily produced by activated T lymphocytes (including CD4⁺ Th1 cells and CD8⁺ cytotoxic T cells), natural killer (NK) cells, and NKT cells.

I. Receptor Complex and JAK-STAT Signaling Pathway

IFN-γ exerts its biological effects by binding to its specific cell surface receptor. The IFN-γ receptor is composed of two ligand-binding subunits (IFNGR1) and two signal-transducing subunits (IFNGR2), forming a tetrameric complex.

• Ligand Binding and Receptor Dimerization: One IFN-γ dimer simultaneously binds to two IFNGR1 subunits, causing a conformational change in the receptor, which subsequently recruits two IFNGR2 subunits to form a functional signaling complex.
  
  

• Activation of JAK Kinases: IFNGR1 is constitutively associated with JAK1 kinase, and IFNGR2 is constitutively associated with JAK2 kinase. Upon receptor aggregation, JAK1 and JAK2 undergo mutual phosphorylation and are activated.
  
  

• Phosphorylation and Dimerization of STAT1: The activated JAK kinases phosphorylate tyrosine residues on the intracellular domain of IFNGR1, providing docking sites for STAT1 protein. STAT1 is then phosphorylated by JAK kinases at the Y701 residue. The phosphorylated STAT1 dissociates from the receptor and forms homodimers (gamma-activated factor, GAF) via its SH2 domain.
  
  

• Nuclear Translocation and Gene Transcription: The STAT1 dimers translocate into the nucleus, where they specifically recognize and bind to the gamma-activated sequence (GAS) in the promoter regions of target genes, initiating downstream gene transcription.
  
  

• Negative Regulatory Mechanisms: This pathway is tightly regulated by mechanisms including protein tyrosine phosphatases (e.g., SHP-1/2), suppressors of cytokine signaling (SOCS) family proteins (particularly SOCS1 and SOCS3), and feedback inhibition by protein inhibitors of activated STAT (PIAS).
  
  

II. Broad Biological Functions

The core function of IFN-γ is to activate macrophages and coordinate innate and adaptive immunity.

• Enhancement of Antigen Presentation:
  
  

  • Strongly induces the expression of major histocompatibility complex (MHC) class I and class II molecules, thereby enhancing the antigen-presenting capacity of all nucleated cells and promoting the activation of CD4⁺ and CD8⁺ T cells by antigen-presenting cells (e.g., dendritic cells, macrophages).
    
    

• Classical Activation of Macrophages:
  
  

  • Induces macrophage polarization towards the M1 phenotype, enhancing their phagocytic and killing capacity.
    
    

  • Upregulates inducible nitric oxide synthase (iNOS), leading to the production of high levels of nitric oxide (NO) to kill intracellular pathogens.
    
    

  • Promotes the production of reactive oxygen species (ROS).
    
    

  • Induces the expression of genes encoding pro-inflammatory cytokines (e.g., TNF-α, IL-12).
    
    

• Immune Cell Differentiation and Polarization:
  
  

  • Is a key driver of Th1 cell differentiation and simultaneously inhibits IL-4-driven Th2 cell differentiation, thereby regulating the type of immune response.
    
    

  • Enhances the cytotoxicity of NK cells.
    
    

• Antiviral and Antiproliferative Effects:
  
  

  • Establishes an antiviral state in cells by upregulating the double-stranded RNA-dependent protein kinase (PKR) and 2'-5' oligoadenylate synthetase (OAS)/RNase L system, thereby inhibiting viral replication.
    
    

  • Exerts direct antiproliferative effects on certain cell types, contributing to its role in anti-tumor immunity.
    
    

• Anti-angiogenesis:
  
  

  • Inhibits angiogenesis in tumors and related pathologies by inducing chemokines (e.g., IP-10/CXCL10) and suppressing angiogenic factors.
    
    

III. Applications in Scientific Research

• In Vitro Cell Models:
  
  

  • Macrophage Polarization Studies: Used to polarize monocytes/macrophages (e.g., THP-1 cells, primary macrophages) into the M1 phenotype.
    
    

  • Antigen Presentation Function Studies: Used to upregulate MHC molecule expression in cell models (e.g., dendritic cells, endothelial cells).
    
    

  • Signaling Pathway Studies: Serves as a classic stimulus for studying the JAK-STAT pathway, particularly STAT1 activation.
    
    

• In Vivo Animal Models:
  
  

  • Infection Models: Used to study the role of IFN-γ in defense against intracellular bacteria (e.g., Listeria), parasites (e.g., Leishmania), and viral infections.
    
    

  • Tumor Models: Used to study its role in tumor immune surveillance, immunoediting, and therapy through injection or genetic overexpression.
    
    

  • Autoimmune and Inflammatory Models: Utilizing IFN-γ gene knockout mice or neutralizing antibodies to investigate its pathological role in diseases such as rheumatoid arthritis and multiple sclerosis.
    
    

• As Experimental Controls and Tools:
  
  

  • Serves as a positive control and standard in ELISA, ELISpot, and intracellular cytokine staining for flow cytometry.
    
    

  • Used as an experimental stimulus for functional validation of T cells (particularly Th1 cells).